Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Difficulties in diagnosing hypertension: Implications and alternatives
H. M. Perry
,
J. P. Miller
Institute for Informatics, Data Science and Biostatistics (I2DB)
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Research output
:
Contribution to journal
›
Article
›
peer-review
43
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Difficulties in diagnosing hypertension: Implications and alternatives'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hypertension
100%
Diastolic Pressure
100%
Hypertensive
75%
Screening Algorithm
50%
Mild Hypertension
50%
High Risk
25%
Clinical Trials
25%
National Health Interview Survey
25%
NHANES
25%
Epidemiologic Studies
25%
Error Types
25%
False-negative Results
25%
Clinical Practice
25%
Classification Accuracy
25%
Error Rate
25%
Significant Benefit
25%
Single Visit
25%
Hypertensive Subjects
25%
General Population Sample
25%
Screening Method
25%
Hypertension Prevalence
25%
Public Health Policy
25%
Statistical Model
25%
Hypertension Risk
25%
Single Measurement
25%
Sequential Screening
25%
Sequential Algorithm
25%
Pressure Value
25%
Population Survey
25%
Sequential Probability Ratio
25%
Mean Pressure
25%
True Prevalence
25%
Sequential Approach
25%
Cost-benefit Analysis
25%
Nursing and Health Professions
Diastolic Blood Pressure
100%
Borderline Hypertension
50%
Prevalence
25%
False Negative Result
25%
Clinical Practice
25%
False Positive Result
25%
Health Care Policy
25%
National Health and Nutrition Examination Survey
25%
Cost Benefit Analysis
25%
Public Health
25%
Medicine and Dentistry
Diastolic Blood Pressure
100%
Borderline Hypertension
50%
Prevalence
25%
Clinical Trial
25%
Cost Benefit Analysis
25%
Cohort Effect
25%
False Negative Result
25%
False Positive Result
25%
Public Health Policy
25%
National Health and Nutrition Examination Survey
25%
Pharmacology, Toxicology and Pharmaceutical Science
Borderline Hypertension
100%
Clinical Trial
50%
Prevalence
50%
Public Health Policy
50%
Biochemistry, Genetics and Molecular Biology
Diastolic Blood Pressure
100%
Clinical Trial
25%
Prevalence
25%